Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSTO1 | P78417 | 2/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | PDE4A | P27815 | 1/20 | 0.77 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.77 |
| ▸ | PSEN1 | P49768 | 4/20 | 0.75 |
| ▸ | TTPA | P49638 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.64 |
| ▸ | USP2 | O75604 | 1/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.64 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.59 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.59 |
| ▸ | PGR | P06401 | 1/20 | 0.54 |
| ▸ | AKT1 | P31749 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21999363 | 1.00 | GSTO1 (1.00) | GSTO1PTPN1MEN1KMT2APDE4A | |
| (+)-Alpha-Tocopheryl Succinate SCHEMBL17749239 | 1.00 | GSTO1 (1.00) | GSTO1PTPN1MEN1KMT2APDE4A | |
| (+)-Alpha-Tocopheryl Succinate SCHEMBL29409614 | 1.00 | GSTO1 (1.00) | GSTO1PTPN1MEN1KMT2APDE4A | |
| (+)-Alpha-Tocopheryl Succinate SCHEMBL29903398 | 1.00 | GSTO1 (1.00) | GSTO1PTPN1MEN1KMT2APDE4A | |
| (+)-Alpha-Tocopheryl Succinate SCHEMBL12628147 | 1.00 | GSTO1 (1.00) | GSTO1PTPN1MEN1KMT2APDE4A | |
| (+)-Alpha-Tocopheryl Succinate SCHEMBL2162349 | 1.00 | GSTO1 (1.00) | GSTO1PTPN1MEN1KMT2APDE4A | |
| (+)-Alpha-Tocopheryl Succinate SCHEMBL134422 | 1.00 | GSTO1 (1.00) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL13309644 | 0.96 | GSTO1 (0.93) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL12535829 | 0.96 | GSTO1 (0.93) | GSTO1PTPN1MEN1KMT2APDE4A | |
| SCHEMBL22199470 | 0.96 | GSTO1 (0.93) | GSTO1PTPN1MEN1KMT2APDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100273871-A1 | ANTICANCER TOCOPHERYL SUCCINATE DERIVATIVES | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-10-28 | — | — | US | claimed |
| US-8461362-B2 | Protein phosphatase 2A-activating agents | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2013-06-11 | — | — | US | disclosed |
| EP-2419414-A1 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS | The Ohio State University Research Foundation (US) | 2012-02-22 | — | — | EP | disclosed |
| US-20100273871-A1 | ANTICANCER TOCOPHERYL SUCCINATE DERIVATIVES | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-10-28 | — | — | US | disclosed |
| US-20100267673-A1 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS | THE OHIO SATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-10-21 | — | — | US | disclosed |
| WO-2010120711-A1 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2010-10-21 | — | — | WO | disclosed |
| EP-1986635-A4 | ANTICANCER AGENTS | UNIV OHIO STATE RES FOUND (US) | 2009-04-22 | — | — | EP | disclosed |
| EP-1986635-A2 | ANTICANCER AGENTS | THE OHIO STATE RESEARCH FOUNDATION (US) | 2008-11-05 | — | — | EP | disclosed |
| US-20080009545-A1 | Anticancer agents | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2008-01-10 | — | — | US | disclosed |
| WO-2007098139-A2 | ANTICANCER AGENTS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2007-08-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273871-A1 | ANTICANCER TOCOPHERYL SUCCINATE DERIVATIVES | SDHA, SDHB, SUCNR1 | GSTO1 191/4885PTPN1 4113/4885MEN1 2933/4885 |
| US-20080009545-A1 | Anticancer agents | SUCNR1, CPS1, HIF1AN | GSTO1 1338/4885PTPN1 2349/4885MEN1 1341/4885 |
| US-20100267673-A1 | PROTEIN PHOSPHATASE 2A-ACTIVATING AGENTS | PPP2CA, PPP2R2A, PPP2R1A | GSTO1 251/4885PTPN1 386/4885MEN1 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.